Figure 4.

Patient classifications made by example signatures applied to representative datasets, showing that the different signatures are essentially detecting as low-risk the low-proliferation subset of ER+/ERBB2- tumors. ER, estrogen receptor.

Wirapati et al. Breast Cancer Research 2008 10:R65   doi:10.1186/bcr2124
Download authors' original image